Every promotional pixel is a legal document.
Pharma digital is not one marketing program. It is three audiences, two regulatory streams, and a review board watching every claim. We build the architecture that keeps HCP, patient, and regulator content separated, compliant, and effective.
One molecule, three audiences
HCP and patient marketing are two different programs.
The same drug carries two entirely separate marketing streams. Merge them and you invite a warning letter. Keep them apart and you need architecture that gates access, matches claims to audience, and never lets one stream leak into the other.
For healthcare professionals
Gated, evidence-dense, and written for people who prescribe.
- Full prescribing information and clinical trial data
- Access gated behind prescriber verification (NPI, DEA, DocCheck)
- Mechanism of action, dosing, and safety in clinical depth
- MSL and Medical Information request pathways
- Off-label handling routed to Medical Affairs, never promotion
For patients and caregivers
Plain-language, fair-balanced, and DTC only where the region permits.
- Indication and benefit paired with risk in fair balance
- Important Safety Information carried on every promotional surface
- Plain-language, health-literacy-aware copy
- Adverse Event reporting built into every form and flow
- DTC advertising only in markets that allow it, gated elsewhere
Eight services, each tagged to the audience it serves.
Every service below is built for the compliance realities of pharma. The badges show which audience streams each one is designed to reach.
Corporate, Product & Brand Websites
Separated HCP and DTC architecture with regulatory gating baked in. Corporate, product, and unbranded disease-awareness sites that keep each audience on the right path.
HCP Portals & Prescriber Verification
Gated professional portals with DocCheck, NPI validation, and DEA integration so clinical depth reaches verified prescribers, and only verified prescribers.
Pharmaceutical SEO
Search built around molecule, indication, mechanism, and brand vs generic terms. Compliant metadata and content that ranks without overstepping a claim.
Multi-Audience Content Systems
One content operation feeding four distinct streams: HCP, patient, payer, and regulator. Shared source of truth, separated outputs, single review trail.
Compliant DTC & HCP Advertising
Paid media that respects region rules: DTC advertising where allowed, HCP-restricted everywhere else, with fair balance carried through every ad unit.
Medical Affairs & MedInfo Digital
Scientific communication platforms, MSL enablement, and Medical Information request systems that keep the medical voice separate from the commercial one.
Patient Support & Adherence Programs
Copay cards, patient portals, financial-assistance flows, and medication reminders that lift adherence while respecting privacy and consent.
Analytics with MLR-Compliant Attribution
Measurement that respects fair balance and HIPAA. Attribution and reporting designed so nothing you track becomes a compliance liability.
Benefit and risk are built together, not bolted on.
Regulators do not read the marketing claim in isolation. They read the whole surface. So we treat fair balance as a structural rule of the page, not a footnote added at the end.
Benefit statement, substantiated by on-label clinical data with citation.
Important Safety Information presented with comparable prominence, plus Adverse Event reporting path and full prescribing link.
- 1
Claims mapped to substantiation
Every benefit statement is linked to the on-label evidence that supports it before it ships to review.
- 2
Risk carried at equal prominence
Safety information travels with the claim across every surface, from landing page to banner to email.
- 3
Adverse Event reporting in the flow
Reporting paths are designed into forms and touchpoints, not tacked on as an afterthought.
- 4
One version, one audit trail
Approved content, ISI, and references stay locked together so a reviewed asset cannot drift out of balance.
Four audiences, matched to the content each one needs.
The same therapeutic story reaches four groups in four different registers. This is the grid we build content operations around.
| Audience | Primary content | Tone & depth | Compliance driver |
|---|---|---|---|
| HCPsGated | Clinical data, MOA, dosingPrescribing info, MSL decks, MedInfo responses | Scientific, full clinical depth | Prescriber verification, off-label separation |
| PatientsFair balance | Disease awareness, supportBenefit and risk, copay and adherence tools | Plain language, health-literacy aware | Fair balance, ISI, AE reporting |
| PayersEvidence | Value and outcomesHEOR evidence, budget impact, formulary dossiers | Economic, evidence-led | Substantiation, non-promotional framing |
| RegulatorsRecord | Substantiation and safetySubmission materials, safety reporting, records | Precise, fully documented | Auditability, AE and record retention |
Medical Affairs & Medical Information.
Between commercial and clinical sits a function no other industry runs the same way. Medical Affairs carries the scientific voice, and it has to stay clearly separated from promotion. We build the digital tools that let it work.
Scientific communications
Congress hubs, publication portals, and evidence libraries built for accuracy and citation.
MSL enablement
Field-medical tools that surface approved scientific content without crossing into promotion.
Medical Information
Request intake, response libraries, and off-label handling routed through Medical, not commercial.
Adverse Event capture
Pharmacovigilance intake wired into every digital touchpoint that a patient or HCP might use.
From Big Pharma to the newest biotech.
The compliance floor is the same. The scale, portfolio, and go-to-market are not. We shape the work to the company type.
Big PharmaBig Pharma
Global portfolios, multi-brand governance, and investor-facing corporate sites that hold up to scrutiny across every region.
BiotechBiotech
Pre-launch and first-launch companies that need investor relations, pipeline storytelling, and a compliant brand from day one.
GenericsGenerics
Volume, formulary, and pharmacy-channel positioning where price, availability, and bioequivalence carry the message.
Specialty & RareSpecialty & Rare
Orphan-drug and specialty-pharmacy marketing built around small populations, HUB services, and patient-support depth.
CROsCROs
Contract research sites focused on trial-sponsor trust, capability depth, and clinical-trial recruitment funnels.
CDMOsCDMOs
Manufacturing and development partners that market capacity, quality systems, and regulatory track record to sponsors.
The compliance layer, in eight parts.
Compliance is not a review step at the end. It is present in every part of how we build, from information architecture to analytics.
MLR review workflows
Medical, Legal, and Regulatory review wired into content operations with clear version control and sign-off trails.
Fair balance enforcement
Benefit and risk co-located by design so promotional surfaces stay balanced across every channel.
Prescriber verification
NPI, DEA, and DocCheck gating that keeps HCP-only content behind verified professional access.
Adverse Event reporting
Pharmacovigilance intake designed into every form, chat, and touchpoint a user might reach.
Multi-region rules
US FDA, EU EMA, UK MHRA, and APAC frameworks handled per market, including where DTC is not allowed.
PhRMA & EFPIA codes
Industry-code compliance built into how we handle HCP engagement, transfers of value, and disclosures.
HIPAA-aware data
Patient data handled with privacy by design, so support programs and analytics stay on the right side of the line.
MLR-compliant analytics
Measurement and attribution set up so tracking never undermines fair balance or exposes protected data.
Pre-launch, launch, and post-launch.
Pharma marketing follows the drug, not the calendar. We map digital work to where a product sits in its lifecycle.
Disease awareness & readiness
- Unbranded disease-awareness and education platforms
- Investor relations and pipeline storytelling
- Congress and publication presence for Medical Affairs
- Clinical-trial recruitment funnels
- MLR workflow and content-ops foundation
Branded rollout, both streams
- Branded product sites with HCP and DTC separation
- HCP portal launch with prescriber verification
- Compliant DTC advertising where the market allows
- Fair-balanced campaign assets across channels
- Payer and formulary evidence materials
Adherence, evidence & growth
- Patient support and adherence program buildout
- Copay, HUB, and financial-assistance flows
- Real-world evidence and outcomes storytelling
- MLR-compliant analytics and optimization
- Lifecycle-management and new-indication support
What pharma teams ask us first.
Let us build the compliant digital your pharma brand needs.
Twelve years, 200+ associates, and 900+ projects. Bring us your molecule, your market, and your review board. We will build the architecture around them.